Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial - Sharman, J P; Egyed, M; Jurczak, W (Lancet, 2020)
(10232):